Januzzi, J. L., Omar, A. M. S., Liu, Y., Murphy, S., Butler, J., Felker, G. M., … Contreras, J. (2022). Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study. Circulation, 146(21), 1638–1640. https://doi.org/10.1161/CIRCULATIONAHA.122.061693

Januzzi, James L., Alaa Mabrouk Salem Omar, Yuxi Liu, Sean Murphy, Javed Butler, G Michael Felker, Iliana L. Piña, Jonathan Ward, Scott Solomon, and Johanna Contreras. “Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study.” Circulation 146, no. 21 (November 22, 2022): 1638–40. https://doi.org/10.1161/CIRCULATIONAHA.122.061693.

Januzzi JL, Omar AMS, Liu Y, Murphy S, Butler J, Felker GM, et al. Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study. Circulation. 2022 Nov 22;146(21):1638–40.

Januzzi, James L., et al. “Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study.” Circulation, vol. 146, no. 21, Nov. 2022, pp. 1638–40. Pubmed, doi:10.1161/CIRCULATIONAHA.122.061693.

Januzzi JL, Omar AMS, Liu Y, Murphy S, Butler J, Felker GM, Piña IL, Ward J, Solomon S, Contreras J. Association Between Sacubitril/Valsartan Initiation and Mitral Regurgitation Severity in Heart Failure With Reduced Ejection Fraction: The PROVE-HF Study. Circulation. 2022 Nov 22;146(21):1638–1640.